Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
04/12/2012 | US20120088280 Gene encoding polymer synthase and a process for producing polymer |
04/12/2012 | US20120088277 Glucoamylase Variants |
04/12/2012 | US20120088273 Novel cellulose and ligno-cellulose active proteins |
04/12/2012 | US20120088272 Methods of generating hybrid/chimeric cells, and uses thereof |
04/12/2012 | US20120088271 Use of an Endogenous 2-Micron Yeast Plasmid for Gene Over Expression |
04/12/2012 | US20120088270 Methods for producing antifungal bifunctional molecules for treating fungal infection |
04/12/2012 | US20120088269 Solution for cell-free protein synthesis, kit for cell-free protein synthesis, and method of protein synthesis |
04/12/2012 | US20120088268 Recombinant production of peptides |
04/12/2012 | US20120088255 Her-2 binding antagonists |
04/12/2012 | US20120088237 Engineering a Novel Methylation-Specific Restriction Endonuclease |
04/12/2012 | US20120087973 siRNA MICROBICIDES FOR PREVENTING AND TREATING DISEASES |
04/12/2012 | US20120087969 Mu-Conotoxin Peptides and Use Thereof as a Local Anesthetic |
04/12/2012 | US20120087940 Vector for treating alzheimer's disease |
04/12/2012 | US20120087939 Methods and compositions for treating and preventing shiga toxin-producing escherichia coli infection |
04/12/2012 | US20120087938 Consensus/ancestral immunogens |
04/12/2012 | US20120087937 Novel compositions |
04/12/2012 | US20120087932 Diagnostic test for virus |
04/12/2012 | US20120087931 Therapeutic and diagnostic anti-hsp70 antibodies |
04/12/2012 | US20120087930 Marker of Streptococcus Anginosus/ Streptococcus Constellatus (MOAC) and Uses Thereof |
04/12/2012 | US20120087927 Antibody containing igg2 having amino acid mutation introduced therein |
04/12/2012 | US20120087923 Antibodies to OPGL |
04/12/2012 | US20120087921 Novel chemokine binding polypeptides capable of inhibiting the course of autoimmunity, inflammation and cancer |
04/12/2012 | US20120087917 Lox and loxl2 inhibitors and uses thereof |
04/12/2012 | US20120087912 Treatment methods using dkk-1 antibodies |
04/12/2012 | US20120087910 Sparc angiogenic domain and methods of use |
04/12/2012 | US20120087909 Neutralizing monoclonal antibodies to respiratory syncytial virus |
04/12/2012 | US20120087901 Engineered Mesenchymal Stem Cells and Methods of Using Same to Treat Tumors |
04/12/2012 | US20120087900 Immunotherapeutic agent |
04/12/2012 | US20120087894 Producer cells for replication competent retroviral vectors |
04/12/2012 | US20120087870 Novel caviidae allergens and uses thereof |
04/12/2012 | US20120087861 Human Anti-Tau Antibodies |
04/12/2012 | US20120087858 Dual variable domain immunoglobulins and uses thereof |
04/12/2012 | DE10237517B4 Verfahren zur An- bzw. Abreicherung von Biomolekülen aus flüssigen oder fluiden Medien unter Verwendung von Schichtdoppelhydroxiden und Verwendung von an einem Schichtdoppelhydroxid an- oder eingelagerten Biomolekülen als anorganischer Vektor A method for enrichment or depletion of biomolecules from liquid or fluid media using Schichtdoppelhydroxiden and use of other on a layered double or embedded biomolecules as inorganic Vector |
04/12/2012 | DE102011006612B3 Aminoglykosid-spezifische Aptamere Aminoglycoside-specific aptamers |
04/12/2012 | DE102010042359A1 Markersequenzen für Multiple Sklerose und deren Verwendung Marker sequences for multiple sclerosis and their use |
04/12/2012 | CA2817191A1 Short rna molecules |
04/12/2012 | CA2813986A1 Closterovirus-based nucleic acid molecules and uses thereof |
04/12/2012 | CA2813903A1 Expression vector for high level expression of recombinant proteins |
04/12/2012 | CA2813901A1 Treatment of sialidase 4 (neu4) related diseases by inhibition of natural antisense transcript to neu4 |
04/12/2012 | CA2813814A1 Tumor specific antibodies and uses therefor |
04/12/2012 | CA2813738A1 Mutant smoothened and methods of using the same |
04/12/2012 | CA2813675A1 Hepatitis c virus gene |
04/12/2012 | CA2813664A1 Methods for semi-synthetic production of high purity "minicircle" dna vectors from plasmids |
04/12/2012 | CA2813554A1 Compositions and methods for diagnosing autism |
04/12/2012 | CA2812940A1 Compositions and methods useful for the treatment and diagnosis of inflammatory bowel disease |
04/12/2012 | CA2812789A1 Consensus antigen constructs and vaccines made therefrom, and methods of using same to treat malaria |
04/12/2012 | CA2812576A1 Maize cytoplasmic male sterility (cms) c-type restorer rf4 gene, molecular markers and their use |
04/12/2012 | CA2812392A1 Macaca fascicularis ccl17 |
04/12/2012 | CA2812389A1 Antibodies binding human collagen ii |
04/12/2012 | CA2811364A1 Methods and compositions for inhibiting viral entry into cells |
04/12/2012 | CA2811087A1 Antibody compositions and methods of use |
04/12/2012 | CA2810915A1 Xylitol-producing strain to which an arabinose metabolic pathway is introduced, and method for producing xylitol using same |
04/12/2012 | CA2808643A1 Selective detection of neisseria meningitidis |
04/12/2012 | CA2801421A1 N-end rule protease activity indication methods and uses thereof |
04/11/2012 | EP2439286A1 The use of ribozymes in the detection of adventitious agents |
04/11/2012 | EP2439280A1 Plants having enhanced yield-related traits and a method for making the same |
04/11/2012 | EP2439279A1 Methods for genetic control of insect infestations in plants and compositions thereof |
04/11/2012 | EP2439278A1 Methods for genetic control of insect infestations in plants and compositions thereof |
04/11/2012 | EP2439277A1 Plants overexpressing SYR polypeptide having enhanced yield-related traits and a method for making the same |
04/11/2012 | EP2439276A1 Method for semi-synthetic production of extremely pure minicircle DNA vectors from plasmids |
04/11/2012 | EP2439275A1 Gene capable of increasing protein content in seed, and method for utilization thereof |
04/11/2012 | EP2439274A2 MULTI-CISTRONIC shRNA EXPRESSION CASSETTE FOR SUPPRESSING SINGLE OR MULTIPLE TARGET GENES |
04/11/2012 | EP2439273A2 Human monoclonal antibodies to programmed death 1(PD-1) and methods for treating cancer using anti-PD-1 antibodies alone or in combination with other immunotherapeutics |
04/11/2012 | EP2439272A2 Human monoclonal antibodies to programmed death 1(PD-1) and methods for treating cancer using anti-PD-1 antibodies alone or in combination with other immunotherapeutics |
04/11/2012 | EP2439271A1 Polypeptide having d-lactate dehydrogenase activity, polynucleotide encoding the polypeptide, and process for production of d-lactic acid |
04/11/2012 | EP2439270A1 Galactosidase derived from bacillus circulans |
04/11/2012 | EP2439269A1 Expression vector for establishing hyper-producing cells, and hyper-producing cells |
04/11/2012 | EP2439267A2 Enzyme preparations yielding a clean taste |
04/11/2012 | EP2439266A2 Enzyme preparations yielding a clean taste |
04/11/2012 | EP2439265A1 Thiolase with improved activity and method of producing biobutanol using the same |
04/11/2012 | EP2439211A1 Plants having improved growth characteristics and method for making the same |
04/11/2012 | EP2438931A1 Improved expression of factor IX in gene therapy vectors |
04/11/2012 | EP2438927A1 Pharmaceutical composition, food or beverage, and methods for these products |
04/11/2012 | EP2438813A1 Insect pest control method |
04/11/2012 | EP2438177A1 Transgenic lsd1 animal model for cancer |
04/11/2012 | EP2438176A1 Methods and compositions for stress tolerance in plants |
04/11/2012 | EP2438175A1 Method for producing natively folded proteins in a prokaryotic host |
04/11/2012 | EP2438174A2 Method for incorporating aliphatic amino acids comprising alkyne, azide or aliphatic ketone functional groups using appropriate trna/trna synthase pairs |
04/11/2012 | EP2438173A2 Biomaterials, compositions, and methods |
04/11/2012 | EP2438172A1 Constructs expressing chimeric receptors and use thereof for the controlled activation of defence response to pathogens in plants |
04/11/2012 | EP2438171A1 Fucosylation-deficient cells |
04/11/2012 | EP2438170A2 Soga polynucleotides and polypeptides and uses thereof |
04/11/2012 | EP2438169A1 Nucleic acid modulators of glycoprotein vi |
04/11/2012 | EP2438168A2 Polynucleotides for multivalent rna interference, compositions and methods of use thereof |
04/11/2012 | EP2438167A1 Therapeutic and diagnostic molecules |
04/11/2012 | EP2438166A1 Method for preparing protein, dna, and rna from cell |
04/11/2012 | EP2438163A1 Polypeptides having cellobiohydrolase activity and polynucleotides encoding same |
04/11/2012 | EP2438156A1 Method for generating a genetically modified microbe |
04/11/2012 | EP2438151A2 Method and system for sample preparation |
04/11/2012 | EP2438082A1 Recombinantly produced allergens |
04/11/2012 | EP2438081A2 Gene for increasing plant weight and method for using the same |
04/11/2012 | EP2438079A2 Nucleic acid delivery compositions and methods of use thereof |
04/11/2012 | EP2437773A1 Method for enhancing phagocytosis of phosphatidylserine-exposing cells |
04/11/2012 | EP2437769A2 Recombinant production of peptides |
04/11/2012 | EP2437592A2 Isolation and targeted suppression of lignin biosynthetic genes from sugarcane |
04/11/2012 | EP2126078B1 Composition and methods for modulating cell proliferation and cell death |
04/11/2012 | EP2119797B1 Method of detecting amplification or deletion in genomic dna fragment |
04/11/2012 | EP2111452B1 Compositions and methods using rna interference of opr3-like gene for control of nematodes |
04/11/2012 | EP2067857B1 Method for production of dipeptide |
04/11/2012 | EP2066709B1 Particles and their use in a method for isolating nucleic acid or a method for isolating phosphoproteins |